Consistent with previous findings and the established role of IL-6 as a hallmark inflammatory marker in COVID-19 patients, we observed a significant increase in IL-6 levels in patients compared to healthy controls during all pandemic waves [20,21]. This evidence concerns the gene IL6 and COVID-19.